About: Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch (gsw) im März 2000 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в березні 2000 (uk) article scientifique publié en 2000 (fr) artículu científicu espublizáu en marzu de 2000 (ast) scientific article published on 01 March 2000 (en)
publication date	wds:Q73547027-D6F77CD0-C68E-464D-BBC7-D3B129729DDC
publication date	2000-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73547027-44F498CB-8428-4940-8500-51241CAC21F4
language of work or name	English
cites work	wds:Q73547027-02C19C39-70AE-47DC-A6E9-FA38388ADBD2 wds:Q73547027-095A2373-699A-40B9-9D9D-D6E0F06AFC2F wds:Q73547027-12D7F139-865E-424E-A5A6-C702BD965310 wds:Q73547027-249D81E3-5ABA-48DE-9ABC-E17102E3EB8A wds:Q73547027-2A5B192A-0F35-44F5-9F3F-EB968650A40C wds:Q73547027-2C0ABD87-428A-4D4A-B201-00645293E32B wds:Q73547027-30773284-C225-4B93-BAE3-7F3D637FB282 wds:Q73547027-320B23B1-004D-4342-89AE-7BFAF2FAE9E9 wds:Q73547027-322C761A-E979-40BE-8807-32884ABF459E wds:Q73547027-37EC9BCE-9606-453A-989E-4B1CC5C0E82C wds:Q73547027-3BB6CE4B-7A1C-40A2-9CD9-84D34B39A830 wds:Q73547027-3DF22FD4-F6A8-4ED8-A5CB-80AB37465FD0 wds:Q73547027-3EE03336-2F15-4C39-A4FB-CA4EE0B1A068 wds:Q73547027-47E2B600-7587-4460-9AC5-908704FF1CDD wds:Q73547027-4C610AFB-1704-4502-869E-89347F41D5EC wds:Q73547027-5B9D7404-17AD-4679-99B4-1100D73B9977 wds:Q73547027-5F34C68E-9C32-443C-ABB3-636C0BFD4443 wds:Q73547027-5F692058-F7C2-4FEA-95F3-AB0DEE21D027 wds:Q73547027-60894A00-1BE4-4DA6-A89C-BEBE3B6F98FD wds:Q73547027-670552F1-DAA1-4E9A-BD4B-243BD0A9BFB1 wds:Q73547027-675A6E34-2E68-4142-9EBB-DB3E596A90A0 wds:Q73547027-69EF55E4-F4F5-4482-83C7-8FC6292A23D2 wds:Q73547027-6A14BE6F-1138-42EB-90B9-920C1A700E8D wds:Q73547027-6A79C3CD-3299-4ED8-BF46-94CE594DFA54 wds:Q73547027-744C8658-9A4E-4175-BC54-715505C0ABCD wds:Q73547027-895DDE99-569F-47BF-85CA-A67E3CB750C8 wds:Q73547027-8DADE543-42A0-4D96-8C6B-E6B0DD4A9918 wds:Q73547027-95CB1942-687F-47EC-AAC9-5D8F538DF4FA wds:Q73547027-A062CD70-0DD4-4DE7-B17C-BBB32AD7146E wds:Q73547027-A29D2D4F-C85F-41F6-B9B3-6EE4CB120B71 wds:Q73547027-A2FD395F-2F89-41EE-9285-95752CB9D1D8 wds:Q73547027-A926A820-4DC3-4A69-A1DA-73040F3F2F9A wds:Q73547027-AF4FF926-747A-42A0-8C43-0AE0DF78104A wds:Q73547027-B605F910-6E7E-49B7-AC1D-589231F63606 wds:Q73547027-B612EE75-214B-4F37-AC2A-4B22291B98D6 wds:Q73547027-D0AEFEDC-4DA2-4EE4-B181-0557B17093EC wds:Q73547027-D4549B98-79C9-4881-B94C-1EB179776640 wds:Q73547027-D962450E-3EBF-4099-948A-17B021114EDE wds:Q73547027-EA13FF11-B8A2-46BD-9976-EB79A356E5DE wds:Q73547027-FB8EF863-6BAA-4CFC-B7A4-6BD097A012F2
cites work	Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide In vivo evidence that cGMP is the second messenger for atrial natriuretic factor Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice TNF-induced cardiomyopathy Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group Negative inotropic effects of cytokines on the heart mediated by nitric oxide Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure Neurohormonal interactions and adaptations in congestive heart failure Activation of human peripheral monocytes by angiotensin II Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure The Neurohumoral Axis in Congestive Heart Failure Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure Angiotensin II-forming pathways in normal and failing human hearts Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure CGP-42112 partially activates human monocytes and reduces their stimulation by lipopolysaccharides. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines Neuroendocrine activity in untreated heart failure Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways
author name string	wds:Q73547027-01EEEBF0-7A03-478F-9992-AD8EAEEDE660 wds:Q73547027-12F8168D-161F-4DB9-B01C-E715EC30A23A wds:Q73547027-2E2194A8-73E0-46A7-AFEB-E5F36AEA3607 wds:Q73547027-2FC5E323-AF6D-4C77-B023-F0839E2A73EA wds:Q73547027-6C127D32-42D3-416A-8187-EB1A93D74FDF wds:Q73547027-7EFCF5B5-23BE-4CCB-970E-06738B5D7478 wds:Q73547027-9DB3A6BF-6FE0-452E-AE3D-8D3F95CBC655 wds:Q73547027-AF9FAF76-AC72-43BA-979A-0B4101DCAF28

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software